Comparison of ATI-5923, a Novel Vitamin K Antagonist, With Warfarin in Patients Requiring Chronic Anticoagulation

NCT00691470 · clinicaltrials.gov ↗

PHASE2,PHASE3

Phase

UNKNOWN

Status

600

Enrollment

INDUSTRY

Sponsor class

Conditions

Atrial Fibrillation
Atrial Flutter
Venous Thromboembolic Disease
Myocardial Infarction
Cardiomyopathy

Interventions

DRUG: ATI-5923
DRUG: Coumadin (warfarin)

Sponsor

ARYx Therapeutics